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Individual expression profiles from EBV transformed cell lines are an emerging resource 
for genomic investigation. In this study we characterize the effects of age, sex, and 
genetic variation on gene expression by surveying public datasets of such profiles. We 
establish that the expression space of cell lines maintains genetic as well as non-germline 
information, in an individual-specific and cross-tissue manner. Age of donor is associated 
with the expression of 949 genes in the derived cell line. Age-associated genes include 
over-representation of immune-related genes, specifically MHC Class I genes, a 
phenomenon that replicates across tissues and organisms. Sex associated genes in these 
cell lines include likely candidates, such as genes that escape X-inactivation, testis 
specific expressed genes, androgen and estrogen specific genes, but also gene families 
previously unknown to be sex associated such as common microRNA targets (MIR-490, 
V_ARP1_01, MIR-489). Finally, we report 494 transcripts whose expression levels are 
associated with a genetic variant in cis, overlapping and validating previous reports. 
Incorporating age in analysis of association facilitates additional discovery of trans-acting 
regulatory genetic variants. Our findings promote expression profiling of transformed cell 
lines as a vehicle for understanding cellular systems beyond the specific lines.  
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Author Summary 
It is well known that measurements of gene expression levels are useful in understanding the 
roles, pathways, and function of genes across the organism under study.  Here we take advantage 
of recent datasets and methods that allowed us to address several questions about aging, sex, and 
genetics, such as: Are age differences reflected in human gene expression levels in more than 
one tissue, is information relating to the individual reflected in EBV transformed cells, and are 
there genetic variants that influence expression of genes? We demonstrate that there are immune 
specific genes that are associated with chronological age in both EBV transformed cell lines and 
kidney, that the common sex associated genes are also reflected in these cell lines and identify 
new gene groups that were not suspected to be sex associated genes, and find variants across the 
genome that are indeed influencing levels of gene expression in this tissue. Future implication 
includes studying aging, sex, and genetic influences in expression levels of other human cell 
lines and tissues. 
 
Keywords:  Gene expression, Aging, eQTL mapping, imputation, heritability, association 
studies, genetics of gene expression, LRP1B, APOE. 
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Genomewide association studies and expression profiling of disease case and control individuals 
are powerful strategies to properly evaluate the genes that impact human health. Recent studies 
have attempted to demonstrate a general overlap between SNPs associated to disease traits and 
those associated to RNA levels in accessible tissues with limited success and new models were 
created to approach a problem that integrates genetics, gene expression, and disease [1,2]. 
Genetic genomics holds the promise to link these paradigms by dissecting all the heritable and 
environmental factors that regulate expression-mediated processes in the cell [3].  Indeed, 
coupled whole genotype and expression data for human lymphoblastoid cell lines have recently 
been analyzed by classical methods to map numerous QTLs by linkage in pedigrees [4,5,6] and 
association in unrelateds [7,8,9].  Integration of genetic and gene expression information in the 
extended pedigree setting has shown association of only a limited number of transcript levels to 
variation in the genome [10].  
The dependencies of a disease trait on age, sex, and heritability from each parent are routinely 
evaluated for consideration in design and analysis of genetic studies of such a trait.  The reported 
association findings motivate exploration of the connections between these factors and gene 
expression phenotypes.  A major challenge has to do with the human system for these studies. 
The transcriptome-wide effects of disease on expression profiles [1] and the infiltration of 
multiple cell types [2] highlight the issues confronted by genetic- genomic investigation in 
primary tissue.  We focus on genetic genomics in lymphoblastoid cell lines that are Epstein-Barr 
virus transformed.  While these lines maintain the DNA of the contributing individual, 
immortalization, tissue specificity, lab culture conditions, cellular phenotypes such as growth 
rate and metabolic state [11], as well as RNA levels of the Epstein-Barr virus used to transform 
the cells may obliterate individual signatures of gene expression, and such effects have been 
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largely ignored in the association analysis of cell-line expression levels as quantitative genetic 
traits for genetic association.  
We thus sought to assess the effects of age, sex, and heritability on transcript levels themselves, 
as reflected by EBV-transformed cells. We hypothesized that age and sex would be covariates of 
expression for many genes, motivating refined analysis of genetic association for these 
transcripts. We consider public data from CEPH extended pedigrees that include expression 
profiles as well as microsatellite and SNP genotypes [12,13]. Such data provide ample 
transmissions to assess heritability [4] and span a wide range of ages [Fig 1a]. In terms of 
genetics, the highly dense, Phase II HapMap [14,15] allows for a finer scale interpretation of the 
linkage signals previously reported [4] in pedigrees that overlap with the HapMap samples. Here 
we have used transcriptional profiles of five tri-generational pedigrees and five trios and 
genotypes of 2.2 million SNPs genotyped by the HapMap Consortium.  Furthermore, we use 
transcriptional profile of 270 individuals in the four HapMap populations to assess sex specific 
signatures in gene expression [7,8]. Such mixed data, of a microsatellite-typed pedigree, array-
typed unrelateds and expression profiles have recently shown to expose large scale transcription 
signatures of disease and genetics [1], and may show much more using methodologies presented 
here to leverage all samples.  
Results 
Age architecture of human gene expression 
Few studies have tried to systematically evaluate the relationship of chronological age and sex 
with expression phenotypes across multiple tissues [16,17,18]. Recent studies in mice have 
catalogued changes in gene expression that are associated with these covariates and 
demonstrated patterns that were conserved across tissues and other patterns that were specific 
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[17,18].  However, no such comparison has been made across tissues in a systematic fashion 
with modest sample sizes and with a broad range of chronological age in a human system. The 
insight into cross tissue conservation of patterns demonstrates the importance of systematically 
addressing this problem in future work.  
We model the age architecture of human gene expression by taking advantage of the broad age 
distribution available in the extended-pedigree setting with three generations and 142 samples 
available to determine the relationship between chronological age and lymphocyte expression 
levels [Fig. 1a,1b][Eq. 1]. 2991 genes are significantly (p=0.01) affected by donor age 
(FDR=0.08). Taking a genomewide approach, we examined the functional annotation of age-
associated transcripts and found enrichment for immune-related genes. A similar phenomenon 
has been observed in systems other than human lymphoblastoid cell lines [16,19,20,21,22,23,24], 
alleviating many technical concerns of a statistical or experimental artifact.  Seeking to further 
validate age-associated expression on a gene-specific resolution, we compared our analysis to 
analogous analysis of human kidney data [16].  These studies examine different tissues and their 
small sample sizes (Nkidney=74,Nlymphoblastoid=142) limit their power to detect association with age, 
therefore complete overlap of associated genes is not expected.   Yet, we find significant overlap 
between the sets of genes whose expression increases in both datasets (57 genes, !2 = 37.52, p-
value = 9.04e-10, see Figure 1c)[Supp Table 2].  Functional analysis reveals genes of the MHC-
class I to comprise 10% of this overlapping set including HLA-A, B, E, F, and HUMMHCW1A 
Cw1 antigen (which maps to HLA-C gene in the genome) and many MHC processing and 
antigen presenting genes.  As previously described in similar studies of aging in mice, different 
cell types, specifically murine hippocampus, motorneurons, and T cells maintain the signature of 
an increased expression level of MHC Class I genes in older mice [19,20,21,22,23,24]. We note 
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that a major concern regarding immune-genes in the kidney had to do with potential tissue 
contamination with immune system cells [16]. It was therefore suggested that an increased 
number of immune cells were present in the kidney of older individuals, resulting in an age-
related increase in abundance of all genes that are expressed specifically in those cells, without a 
true change in expression level in any particular cell type. A related potential source of 
artifactual age-associated expression of immune-related genes could be due to increase overall 
expression within immune cells contaminating the kidney tissue.  The data reported here from 
lymphoblastoid cell lines proves the overexpression of this set of genes is genuine. This 
signature of aging and the enrichment of transcripts associated with chronological comes as a 
surprise since the cell lines have been immortalized.  The conserved signature across kidney and 
EBV transformed cell lines demonstrates the utility of cross tissue comparison of gene 
expression signatures. No significant overlap is detected across these tissues beyond this set of 
genes, nor among genes that decrease in expression with age (8 genes, !2 = 0.973, p-value = 
0.3239).  We predict that among the factors that can attribute to this absence of overlap include 
small sample sizes used in each individual study and that age attributes only a modest effect to 
expression change in either tissue being studied. 
We considered hierarchical clustering of all 951 transcripts associated with old-age expression. 
[Figure 1d] shows the tightest (r2 = .78) cluster in this data.  It includes 11 genes including 
Apolipoprotein E (APOE), which validates in both human kidney [16] and murine hippocampus 
data in mice [22] as age associated.  As common genetic variation in APOE is associated to 
numerous late-onset conditions (e.g. cardiovascular disease [25], dislipidemia [26], colorectal 
cancer [27], Alzheimer’s disease [28] as well as longevity [29]) we sought to further understand 
the expression signature of this cluster through genetic lens.  We scanned the data for potential 
!"#$%&%'(%!"%
%
genetic mediators of the age-related expression differences observed.  We used dense SNP 
genotype data available by the HapMap for individuals from two generations of CEPH.  To 
maximize statistical power we increase sample size by inferring SNP genotypes for their third-
generation descendants based on available microsatellite and SNP data [10] (see Methods).  
Given the derived sample dataset with overlapping genotype and gene expression we fit a model 
that would test for age by genotype interaction in the expression dataset with the 69 samples 
available (see Methods).  We report 11 variants across 4 loci, as showing significant (p-value < 
1e-6) age by genotype interaction in the dataset.  In particular, these variants include rs10928136 
a SNP located in the intronic sequence of LRP1B, a receptor of APOE [Figure 1d,2, Supp Table 
3] [30].  Further investigation and replication is warranted as it could potentially reveal some 
novel insights into the regulation of APOE.  
Sex architecture of human gene expression 
Sex is perhaps the most obvious biological division of humans, with manifestations ranging from 
genetics to appearance to health [31,32].  Understanding the partition of genome expression 
differences is important to understand the role of sex in genome science.  While EBV 
transformed cell lines carry the sex specific karyotype, manifestation of such expression 
differences in these cells is yet to be evaluated. To properly quantify these differences we use 
existing HapMap cell line measurements in the GeneVar dataset [7] and derive common 
signatures that are shared across all four populations.  Furthermore, we investigate the 
enrichment of genes with sex derived expression using Gene Set Enrichment Analysis (GSEA).  
To analyze changes in gene expression with sex in human lymphocytes, we used 90, 90, 45, 45 
individual lymphoblastoid cell lines samples of CEPH, YRI, JPT, and CHB ancestry. To guard 
against statistical concerns of population stratification, we first took a conservative approach and 
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analyzed each population separately.  We used a linear regression model to identify genes that 
showed a statistically significant change in expression with sex (Methods).   Despite the limited 
sample size, for 3 (YRI, JPT, CHB) of the 4 populations we saw a significant (p-value < 1e-10) 
enrichment of transcripts whose expression is associated with sex, compared to random 
expectation [Figure 3].  We note that CEU/CEPH cell lines were collected much earlier than the 
other cell lines from the pertaining individuals and might be an explanation for the lack of 
overdispersion of sex associated genes in that population. This observation would spark concern 
about CEPH cell lines. However, for both males and females, there is significant overlap 
between the genes that are expressed in that specific sex across the board for the four populations 
(including CEPH) in all chromosomes [Supp Table 1]. Hence, this only indicates that our power 
is limited for the CEPH cell lines to robustly detect any gender specific expression changes and 
combining all four populations would leverage detection. As expected, transcripts associated 
with males in one population do not significantly overlap those with opposite association in other 
direction, suggesting the overlap in the same direction is indeed significant, rather than an 
artifact of the scoring method.  When we restrict the analysis to the autosomes we observe 
significant overlap in 5 of the 6 pairwise comparisons, implying a signature of autosomal genes 
that are expressed differentially between males and females.   
Encouraged by our ability to detect significant sex association even with only dozens of samples 
in each analysis of a single population, we sought to enhance power by combining the statistic of 
the four populations. We merged the 3,637 transcripts [expected = 2956] which were 
preferentially expressed in males in all four populations and merged their p-values using Fisher’s 
exact test method (see methods). The list of genes ranked by combined p-values was examined 
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for enriched gene sets [33]. Similar analysis was applied to the set of 2,567 female-
overexpressed. 
Gene Set Enrichment Analysis   
In the context of obvious biological sex differences in gene expression (sex chromosomes) we 
would not expect to observe X chromosome genes to be higher expressed in males or Y 
chromosome genes to be expressed at all in females.  Single gene analysis at a = .01 results in a 
single gene list that of 3 X-chromosome genes that overlap in two or more populations and are 
higher expressed in males than in females (NLGN4 [autism related], SCML1, PNMA3) , and a 
single gene on the Y chromosome, PRKY.  PRKY is located on chromosome Y, near the 
boundary of the pseudo autosomal region. It is known that abnormal recombination between this 
gene and a related gene on chromosome X is a frequent cause of XX males and XY females [32]. 
Due to the high sequence similarity with its homolog, PRKX, this observation may be attributed 
to probe similarity.  
Cytogenetic gene sets on sex chromosomes whose expression is found to be sex-dependent 
include ChrYq11 for males and ChrXp11 and ChrXp22 for females. The overexpression of 
autosomal Chr18q22 genes is also found to be enriched in males [Supplementary Table 
Website]. Curated gene sets that are observed to be overexpressed in males include testis 
expressed genes, genes upregulated in pulpal tissues from extracted caries, and ribosomal protein 
genes. In females, we observe genes escaping X inactivation to be upregulated, genes involved in 
the androgen and estrogen metabolism pathway. Motif gene sets that are significantly 
upregulated in males (7 sets, nominal p-value < .01) and females (2 sets, nominal p-value<0.05) 
include microRNA motifs; mir-489, mir-342, mir-500(m), and mir-490 (f). Lastly, 14 out of 30 
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computational, cancer-associated gene sets are significantly overexpressed in males at nominal 
p-value < .01. 
Genetics of gene expression 
Continuing our analysis of the genetic and non-genetic factors that influence gene expression 
levels, we surveyed the relationship between SNP variation and gene expression levels. We use 
CEPH family extended pedigree expression data previously generated along with sparse 
microsatellite data, and highly dense imputed and typed HapMap Phase II SNP data to fine map 
expression traits. An obvious concern is that the quantitative traits under study of the individuals 
in the setting of this study are not truly independent and it would not be suitable to treat them as 
such. However, genomic control [38,39,40] [(See Methods) permits dependent outcomes to be 
treated as independent observations and the computed statistics can be adjusted, taking care of 
any relatedness and/or inherent bias in the data.  
Of obvious interest is to assess the power gains or loss in analysis of genetics of gene expression 
by adjusting for the covariates (age and sex specifically) that we examine for relationships with 
expression traits. In our study we scan all expression phenotypes and their neighboring SNPs in a 
5Mb window for cis-acting variants and apply genomic control by selecting 100 random SNPs 
with MAF > 0.15 drawn across the entire genome. 
We focus on a linkage peak on chromosome 6, reported to affect the expression of six transcripts 
[4] that reside on different chromosomes. We used HapMap-typed and inferred SNP genotypes 
to fine map this linkage peak. and find rs2157337 to be associated with the expression of these 
six genes (Supp Table 4). Evaluation of this effect in HapMap expression profiles replicated 
HLA-DRB3 association with this SNP, which is 1.4MB away from the transcript (Supp Table 4). 
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Analysis of cis regulatory variation allows for a systematic evaluation of power to replicate 
associations across this and the GENEVAR study as such analysis enjoys a lighter burden of 
multiple testing and therefore numerous such associations have been reported [6,7,8,9]. Of the 
23,880 transcripts that were tested, we detect significant (p-value < 1e-5) association in CEPH 
pedigrees with at least one SNP in cis for 494 transcripts after genomic control without adjusting 
for age and sex, and 477 after adjusting for age and sex [Supp Table 5a,b & Supp Fig. 1], 339 of 
which overlap for both models. Each of the gene sets that did not overlap between these two 
models (155 and 138 genes, respectively) had a subset of 22% of its members (35/31 genes, 
respectively) map well to the GeneVar dataset, a third of which (12/11 genes, respectively) were 
validated by the GeneVar analysis. This validation rate can be contrasted with the 339 snp-gene 
pairs that agreed with both models, where 83 mapped well and 67 snp-gene pairs were validated. 
The results suggest similar power for both models of association, with and without correcting for 
age/sex, with different genes better detectable by different analyses[1].  
Analysis of regulation by cis-variation also allowed examination of the results in the context of 
disease association, as pointed out by recent studies [35,36] In particular, we also find rs6969930 
to be a cis acting determinant of IRF5 gene expression phenotype (p-value = 1.11e-16, see 
methods) that confers risk to systemic lupus [35], and rs7216389 a cis acting determinant of 
LOC51242 or ORMDL3 gene expression (p-value = 3.68e-06) that confers risk to childhood 
asthma [36].   
Discussion 
The regulation program of a cell ranges from constant expression of certain transcripts to 
variable transcript levels, responsive to stimuli and conditions. Individual factors affecting 
transcription profiles are unique in affecting steady-state measurements, yet facilitate 
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examination of inter-sample variation. In this work we surveyed factors affecting individual 
expression of a large fraction of the transcriptome in a tissue available for diagnostics, reporting 
pervasive effects of donor age, sex, and genetic variation on expression levels in lymphoblastoid 
cell lines. While genetics provides an individualized mechanism of information transmission to 
explain cis-acting variation and sex-dependent expression, and the latter is supported by 
chromosomal location of the detected transcripts, the involvement of miRNA families in sex-
specific expression is suggestive of a mechanism for this regulation. 
It is less obvious how age affects many transcripts in such cell lines under controlled conditions, 
may be consistent with epigenetic mechanisms. Specifically, age-related MHC-I expression 
across tissues alleviates the concern of artifacts, and validations across model systems rules out 
trends specific to human aging, like history or changes in health and immunization policy.  
Together, our observations are points in favor the use of cell line expression and genetics as a 
model system for regulation in the entire organism, and motivate further investigation of similar 
datasets. Furthermore, bearing in mind that both expression and SNP arrays revolutionized 
disease research by providing genomewide observations on potential effects and causes of 
clinical conditions, the combined analysis of expression, genetics and disease is an attractive 
goal. Specifically, our results suggest that improved understanding of the individual-specific 
variables affecting transcriptional programs will facilitate better using expression profiles as 
intermediates in mapping connections between genetic variation and disease.  
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Methods 
Overall strategy of accumulating data and power for genetics of gene expression 
We seek to integrate genetics and other factors that might give insight into the sources of 
variation in gene expression measurements in human cell lines.  Gene expression measurements 
of 23,880 transcripts were previously collected from lymphocytes in individuals from CEPH 
extended pedigrees [4]. We use HapMap Phase II genotypes from individuals in CEPH Trios 
1345, 1346, 1358, 1375 and a Duo 1349.  We integrate HapMap Phase II genotypes from 
complementary trios in CEPH families 1334,1340,1350,1362, and 1408 along with microsatellite 
and SNP data [12,15]. We perform imputation of 3M markers across all available sibships in the 
overlapping trios in the HapMap by integrating microsatellite and SNP data with our own 
implementation of the algorithm described in [10] and use 43 of those individuals for the current 
study. By doing so, we increase our sample size from 26 individuals to 69 individuals with 
densely typed genotypes and gene expression traits. Family sample sizes: 1334 (9), 1340 (8), 
1350 (10), 1408 (12), 1362 (17). Age data for individuals in the sample is available for 65 
individuals. 
Age association to gene expression levels 
To understand the effect of chronological age as a source of variation in gene expression levels 
across the entire set of transcripts we fit [Eq. 1] to 142 individuals in the gene expression array 
with pertinent age data available 
 (1)                        
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where the family component is added to adjust for any inflating factors that might be caused by 
differences in age of the pedigrees themselves confounding the analysis that possibly could 
explain genetic driven differences rather than age driven differences. One sided p-values were 
computed for each component. For direct comparison with the Kim et al. analysis of the kidney 
data we used a consistent model that would test the null hypothesis of no effect of chronological 
age on gene expression measurement. 
Sex association to gene expression levels  
For the analysis of genes that are differentially expressed between males and females we applied 
a simple regression model which translates to the standard t-test.  
(2)    
One sided p-values were computed since direction of effect is known. 
 
Gene Set Enrichment Analysis of differentially expressed sex genes 
We used GSEA implemented in GSEA-P –JAVA version of the software Gene Set Enrichment 
Analysis [33]. Our goal was to understand what gene sets were enriched for higher expression in 
males and higher expression in females. Thus, we used the weighted version with Illumina 
mapping and all four populations. 
 We also applied Fisher’s method to combine the four separate analyses.  
Fisher’s method is a meta-analysis technique for combining extreme value probabilities from 
each test into one test statistic having a chi-square distribution: Suppose there are n independent 
tests with independent continuous test statistics and suppose the null hypotheses are all true, so 
that the p-values pj are i.i.d. U[0.1]. Then ln(pj) are i.i.d. standard exponential variables and 
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2ln(pj) are i.i.d. exponential with parameter !, i.e. chi-squared with 2 d.f.  Thus 
is chi-squared with 2n degrees of freedom. Using that we can decide when to reject the null 
hypothesis that all the separate hypotheses are true. 
    
Association Analyses 
The association analysis was performed after applying quantile normalization to the set of 23,880 
gene expression measurements reported [4] with the 69 individuals with genetic and gene 
expression overlap. SNP genotypes were obtained from build 21 HapMap Phase II. Genomic 
positions of SNPs were translated to build 36 of the human genome. Association analysis was 
restricted to SNPs with minor allele frequency above 15%, hence resulting in 1,564,089 SNPs.   
Cis-associations 
For a focus on cis-acting variants we concentrated on a 5MB (+/- 2.5 MB) window of the start 
and end sites of the 60mer probe sequences.  We selected 100 random SNP variants across the 
genome with minor allele frequency (MAF) > 0.15 for genomic control variance inflation factor 
estimate calculations under the assumption that 100 randomly selected loci across the genome 
would be representative of 100 null loci.  
Correcting family bias introduced in the genetics of gene expression analysis 
We use the variance inflation factor robust estimator outlined by Roeder et al. [38,39,40] to 
control for overdispersion in our test statistic distribution for all of our genetic models. Let Y be 
the quantitative trait that is influenced by the genotypes at numerous loci. To test if a single locus 
is associated with the phenotype we work with the model 
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We test the null hypothesis whether the slope b1 is 0. We can define                                                                                                                                                         
and let r = Cov[Yi , Yk] denote the covariance of phenotypes of individuals in the same 
subpopulation as outlined in [38]. The usual estimator of the parameter of interest is the least 
square estimate and among the factors that perturb the distribution of the least square estimate 
from that expected in typical regression setting include (i) positive correlation among subjects 
where the variance is increased over that expected under the independence model. When bias is 
also introduced it results in additional over dispersion [39] which is automatically corrected for 
by Genomic Control [38].  If we define the standard error (SE) term that would be obtained by 
assuming that the phenotype observations are independent as indicated in [39] we can estimate b1   
at M loci. A subset of loci that can be designated as null loci, or any set of loci for which the 
majority are not associated with the quantitative trait suffice to proceed with the genomic control 
procedure. We can compute our T statistic in which family structure or any inherent bias is 
ignored by estimated b/SE.  Under the null hypothesis and for large sample sizes T is 
approximately distributed N(0,l), where l = h2 + t2, in which h2 is proportional to the square of the 
expected bias of the test statistic and t2 is the increase in variance due to the correlation among 
subjects. Then, Tk
2 / l is distributed as c1
2.  The inflation factor l can be robustly estimated using 
(4)                                      
}456./),...,({ˆ 221 MTTmedian=! . 
Then we compare Tk
2 / estimated(l) with c1
2 to determine whether the locus is significantly 
associated with the quantitative trait. 
  Genomic control for full model: 
To test whether or not adding the age and sex terms increased power to detect cis associations we 
proceeded with the method proposed in Roeder et al. [39].  The linear regression model 
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(5)                                    
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where we are interested in the estimate of b1 .  Assuming independent observations SE[b1] is the 
standard error of the beta estimate computed when fitting the model, t2  is the inflation factor 
obtained when fitting with a simple additive model as in equation (3) , and H is a small positive 
term that accounts for a slight decrease in the inflation term obtained when fitting equation (5) 
rather than equation (3).  Devlin et al. demonstrate that t2 -H   remains constant across the 
genome in simulations and therefore Genomic Control applies when fitting a more complex 
model, and inflation factor is now t2  - H [39]. To test for multiple effects simultaneously an F-
test is appropriated based upon sum of squares where  
(6)                       
))(/())()(( fullMSEdffullSSEreducedSSEF !"=
, 
where df is the difference in degrees of freedom  between the full and reduced models. Since we 
are interested in a single locus with multiple terms in the model and we want to asses H in the 
genome then df =1. Consequently, by simply computing the F-statistic in (6) for the loci under 
investigation as well as a set of null loci estimating l is based upon the median of the tests 
obtained from the null loci and adjusting the F-statistic for the variance inflation is done by 
dividing by l. Since df =1 in this case and we are not testing multiple loci at one df.  Our lambda 
estimate is 
(7)                                
}456./),...,({ˆ 1 MFFmedian=!  . 
Then, we evaluate the genotype effect as such. 
 
Age by genotype interaction model 
Genome-wide age by genotype interaction model for APOE expression level was done via: 
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A sex by genotype term was excluded since empirical data [ref table with association 
corrections] suggests that the intersection between age-associated and sex-associated transcripts 
is very small and added degrees of freedom in a model would be overly conservative. 
Transcript Genomic Locations 
We used all 23,880 probes in this analysis.  Absolute genomics positions of transcripts were 
obtained by querying the 60mer sequences against the reference human genome nucleotide 
sequence NCBI build 36 using the MegaBLAST search program [37] SNP positions were 
mapped to DB SNP build 126 and its complementary human genome nucleotide reference build 
36. These positions were used to determine the absolute distances between the SNP and 
transcript. 
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Figure Legends 
Figure 1.  (a) Age distribution of CEPH indivduals analyzed in this study. (b) P-P plot for 
association with age across all genes reveals large excess of  age-associated genes in EBV 
transformed cell line with extended pedigree expression data, (c) Overlap of age associated genes 
between kidney and EBV cell lines: The sets of genes whose expression level increases with age 
significantly overlap across both datasets.  (d) Clustering expression signatures of genes across 
the available set of individuals revealse a tight cluster of age-associated genes including APOE. 
Figure 2. Frequency of p-value for association with sex across different HapMap populations. In 
CEU (a), the distribution of p-values is consistent with the null expectation In YRI (b), JPT (c),  
and CHB (d) there is a significant excess  of sex-associated genes. 
Figure 3. Genomewide p-values for association of HapMap SNPs to APOE expression. (a) P-
values for significance of the regression term for Age by genotype interaction contributing to 
APOE expression, (b) P-values for an additive model for association to APOE expression. 
Supplementary Figure 1. Pie chart of cis variants discovered under different models: without adjusting 
for Age and Sex, fitting Yij = Boj+B1j!Gentoype+" and with adjustment for age and sex as covariates, 
fitting Yij = Boj+B1j!Gentoype+B2j!Age+B3j!Sex+". 339 cis acting variants are discovered by applying 
either model and then applying genomic control. 138 additional cis acting variants are discovered by 
adjusting for age and sex and another set of additional 155 cis acting variants are accepted by adjusting 
for age and sex.   
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